SALICYLANILIDES ENHANCE ORAL DELIVERY OF THERAPEUTIC PEPTIDES

摘要

This invention pertains to the surprising discovery that salicylanilides, e.g., niclosamide and/or niclosamide analogues when orally administered in conjunction with a peptide pharmaceutical (e.g., a class A amphipathic helic al peptide as described herein) significantly increases the bioavailability of that peptide. Methods of peptide delivery using such "delivery agents" an d pharmaceutical formulations are provided.